Facebook Linkedin RSS Twitter Youtube
Home 2024

Machine learning

A Solution to Industry’s Lentiviral Vector Challenge?
Bioprocessing

A Solution to Industry’s Lentiviral Vector Challenge?

Advanced Therapy Needs Well-Controlled Processes to Benefit from AI
Artificial Intelligence

Advanced Therapy Needs Well-Controlled Processes to Benefit from AI

Expanding Imaging for Bioprocess Applications
Bioprocessing

Expanding Imaging for Bioprocess Applications

Shape-Shifting T Cells Signal Activity State
Artificial Intelligence

Shape-Shifting T Cells Signal Activity State

Machine Learning Digs Up a Treasure Trove of Antimicrobial Peptides
Artificial Intelligence

Machine Learning Digs Up a Treasure Trove of Antimicrobial Peptides

Upstream Bioprocessing: Virtual Bioreactors Get Real
Bioprocessing

Upstream Bioprocessing: Virtual Bioreactors Get Real

Accelerating the Search for Therapeutic Antibodies
Sponsored

Accelerating the Search for Therapeutic Antibodies

Simple, Scalable Absolute Concentrations in Untargeted Metabolomics
Artificial Intelligence

Simple, Scalable Absolute Concentrations in Untargeted Metabolomics

Bud-wiser: DOD Backs A-Alpha Bio for Biothreat Preparation
Artificial Intelligence

Bud-wiser: DOD Backs A-Alpha Bio for Biothreat Preparation

Viral Advantage: Prologue Medicines is Here to Release the Viral Proteome’s Therapeutic Potential
Artificial Intelligence

Viral Advantage: Prologue Medicines is Here to Release the Viral Proteome’s Therapeutic Potential

123...32Page 1 of 32
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.